Clinical trial Recruiting at 1 site Interventional Ages 19 to 35

Adaptive ankle exoskeleton controller to personalize walking support

Official title: Controller Development to Enable Individualized Assistance in Robotic Ankle Exoskeletons

Run by University of Nebraska · NCT07393971 · Data updated 2026-11-12

Researchers will test a real-time controller for a robotic ankle exoskeleton that learns how you walk and adds the right amount of help to make walking easier.

Quick facts

Study typeInterventional
Ages19 Years to 35 Years
SexAll
Enrollment6 (estimated)
SponsorUniversity of Nebraska
Academic / other
Locations1 site (Omaha, Nebraska)
StatusRecruiting
StartedAugust 15, 2026
Main results expectedAugust 2028
Study endsDecember 2028
Registry record updatedNovember 6, 2026
Trial IDNCT07393971 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy young adults who can walk independently on a treadmill for at least 10 minutes and can wear an exoskeleton with safety gear.

Probably not a fit

Individuals who have neurological or cardiovascular conditions or current lower-extremity injuries may not benefit and are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project develops and tests a real-time adaptive controller for a bilateral ankle exoskeleton that personalizes assistance to each user. The system uses human-in-the-loop optimization and musculoskeletal modeling to adjust torque magnitude and timing to minimize metabolic cost and improve muscle activation during walking. The goal is to provide faster, more natural, and more efficient walking by tailoring support to individual gait patterns. The study is conducted with healthy young adults to evaluate performance and safety of the Biomotum device. If successful, the approach could inform future wearable robotics that adapt to users in real time.

Why it matters

Potential benefit: If successful, the controller could make walking with an ankle exoskeleton feel easier and more efficient for users.

How similar studies have gone: Prior work with wearable exoskeletons and human-in-the-loop optimization has shown promise in adapting assistance to individuals, supporting the potential effectiveness of this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* able to walk independently on a treadmill for 10 minutes,
* free of neurological, cardiovascular, pulmonary, or musculoskeletal conditions that limit walking and exercising,
* no current lower extremity pain or injury,
* able to wear an exoskeleton and safety harness, can provide informed consent

Exclusion Criteria:

* history of neurological disease that affected gait or balance,
* current or recent lower extremity musculoskeletal injury or surgery,
* chronic lower extremity pain during walking,
* inability to participate in moderate-intensity exercise,
* require an assistive device for walking,
* any metabolic or systemic diseases that may be exacerbated by exercise

Where it's running

  • Biomechanics Research Building, University of Nebraska at Omaha
    Omaha, Nebraska, United States
    Recruiting

Study contacts

  • Principal investigator: Farah Fallahtafti, PhD — Department of Biomechanics, University of Nebraska at Omaha
  • Study coordinator: Farah Fallahtafi, PhD
  • Email: ffallahtafti@unomaha.edu
  • Phone: 4025543075

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.